Park West Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Park West Asset Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,397,212	Closed	-$40.9M	–	183
2021 Q3	$40.9M	Hold	14,397,212	–	–	0.97%	25
2021 Q2	$37.7M	Hold	14,397,212	–	–	1.07%	28
2021 Q1	$36.2M	Hold	14,397,212	–	–	1.1%	24
2020 Q4	$35.6M	Buy	14,397,212 +5,223,804	+57%	+$12.7M	0.74%	32
2020 Q3	$28.9M	Buy	+9,173,408	New	+$29.3M	1.12%	32
2017 Q1	–	Sell	-400,000	Closed	-$848K	–	85
2016 Q4	$848K	Buy	+400,000	New	+$1.12M	0.07%	58

Park West Asset Management's PDLI Position: Q4 2021 in Review

Park West Asset Management sold out of PDL BioPharma, Inc. (PDLI) in Q4 2021, closing a stake of 14,397,212 shares — an estimated $40.9M sold.

Park West Asset Management first reported a position in PDLI in Q4 2016 and held it in 6 quarters. The position peaked at $40.9M in Q3 2021. 5 funds tracked by Wall St. Rank hold PDLI as of Q4 2021.

Park West Asset Management reported no remaining PDL BioPharma, Inc. position as of Q4 2021 after selling out during the quarter.
Park West Asset Management sold 14,397,212 PDL BioPharma, Inc. shares in Q4 2021, an estimated $40.9M.
Park West Asset Management first reported a position in PDL BioPharma, Inc. in Q4 2016 and held it in 6 quarters.
Park West Asset Management's PDL BioPharma, Inc. position peaked at $40.9M in Q3 2021.
5 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2021.

Based on Park West Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.